DrugPatentWatch Database Preview
Casi Pharms Inc Company Profile
What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?
CASI PHARMS INC has twenty-five approved drugs.
Summary for Casi Pharms Inc
| US Patents: | 0 |
| Tradenames: | 23 |
| Ingredients: | 23 |
| NDAs: | 25 |
Drugs and US Patents for Casi Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casi Pharms Inc | ENTECAVIR | entecavir | TABLET;ORAL | 206672-002 | May 11, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Casi Pharms Inc | REPAGLINIDE | repaglinide | TABLET;ORAL | 078555-002 | Jan 22, 2014 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Casi Pharms Inc | LISINOPRIL | lisinopril | TABLET;ORAL | 075994-003 | Jul 1, 2002 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
